Announcements Trials
Browse Landscape

Phase

Phase 2 51Phase 1/2 23Phase 1 12Phase 3 4Phase 4 3Phase NA 2Phase EARLY_PHASE1 2Phase 2/3 2

Status

Completed 9Active not recruiting 7Recruiting 6Terminated 4Unknown 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

fludarabine 17Cyclophosphamide 16Positron Emission Tomography Computed Tomography 4Oncolytic Virotherapy 4Metformin 468Ga-pentixafor 4lenvatinib 3Radiosurgery 3Pemetrexed 3Paclitaxel 3Melphalan 3Immunotherapy, Adoptive 3Gemcitabine 3Cholestanetriol 26-Monooxygenase 3Carboplatin 3toripalimab 2sintilimab 2pembrolizumab 2gallium Ga 68 dotatate 2gallium 68 PSMA-11 2fludarabine phosphate 2alpha-Synuclein 2Progesterone 2Nivolumab 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Influenza Vaccines 2Fluorodeoxyglucose F18 2Ethiodized Oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Nivolumab × Clear all
NCT04570683 2020-09-30

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas

Bispebjerg Hospital

Phase EARLY_PHASE1 Unknown
30 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT03371992 2020-03-27

NO3DEXPL

Nilogen Oncosystems

Phase EARLY_PHASE1 Unknown
25 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡